Lorenzo Algarra-Algarra

12PUBLICATIONS
116CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursOtorhinolaryngologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 08, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study.

|May 07, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.

|May 04, 2026
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

|Apr 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

|Feb 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard

|Jan 09, 2026
CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry.

Esther Prados de la Torre, Josefina Serrano, Eva Barragán

Pageof 2

Frequent Collaborators

10 joint publications

Pau Montesinos

8 joint publications

Juan Miguel Bergua-Burgues

7 joint publications

David Martínez-Cuadrón

6 joint publications

Teresa Bernal Del Castillo